STTK

Shattuck Labs
STTK

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$48.38M
EV
$-9.32M
Shares Outstanding
47.90M
Beta
1.73

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$2.46
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Shattuck Labs, Inc.

gainify
STTK

Shattuck Labs, Inc.

STTK

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovari...

Sector

Healthcare

Industry

Biotechnology

CEO

Schreiber, Taylor

Employees

44

IPO Date

2020-10-09

Headquarters

500 West 5th Street, Suite 1200, Austin, Texas, 78701, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.